Artiva Biotherapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -666 | -666 | -662 | |
EBITDA | -23,647 | -22,850 | -20,106 | -20,866 |
EBIT | -25,005 | -23,516 | -20,772 | -21,528 |
Net Income | -25,005 | -23,516 | -20,772 | -21,528 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -41,962 | -21,192 | -15,147 | -19,801 |
Cash | 301,454 | 20,955 | 26,701 | 25,508 |
Basic Shares | 39,413 | 24,678 | 24,444 | 24,481 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $251 | $33,492 | $4,931 |
Gross Profit | -2,597 | 251 | 33,492 | 4,931 |
EBITDA | -81,268 | -56,062 | -25,358 | -57,177 |
EBIT | -83,865 | -58,493 | -27,624 | -58,335 |
Net Income | -83,865 | -58,493 | -27,696 | -58,388 |
Net Change In Cash | 0 | 251 | 33,492 | 4,931 |
Free Cash Flow | -79,338 | -55,674 | -50,688 | -57,128 |
Cash | 26,701 | 40,235 | 53,504 | 102,531 |
Basic Shares | 24,444 | 24,363 | 23,281 | 17,583 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.63 |
2026-03-31 | -$0.95 |
2025-12-31 | -$0.84 |
2025-09-30 | -$0.88 |